Kidney Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan Kettering's current clinical trials for kidney cancer. To learn more about a study, choose from the list below.

Showing 19 trials
Title Investigatorsort icon
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen, MD
A Phase I Study of BGJ398 in Patients with Advanced Urothelial Cancers
[Protocol 14-218]
Bajorin, Dean, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208]
Coleman, Jonathan, MD
Cabozantinib versus Sunitinib for Treating Previously Untreated Locally Advanced or Metastatic Renal Cell Cancer
[Protocol 14-072]
Feldman, Darren, MD
A Phase I Study of CB-839 in Patients with Advanced Solid Tumors
[Protocol 14-111]
Harding, James, MD
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David, MD
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel, MD
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria, MD
A Phase III Study of Cabozantinib versus Everolimus in Patients with Progressive Kidney Cancer
[Protocol 13-124]
Motzer, Robert, MD
A Phase II Study of MPDL3280A Alone or with Bevacizumab versus Sunitinib Alone in Patients with Previously Untreated Advanced Renal Cell Cancer
[Protocol 13-212]
Motzer, Robert, MD
A Phase III Study of Nivolumab plus Ipilimumab versus Sunitinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
[Protocol 14-199]
Motzer, Robert, MD
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil, MD, PhD
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil, MD, PhD
A Phase I Study of Nivolumab in Combination with Sunitinib, Pazopanib, or Ipilimumab in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin, MD
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin, MD
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin, MD
A Phase I/II Study of Pazopanib plus MK-3475 (Pembrolizumab) in Patients with Previously Untreated, Inoperable Advanced Kidney Cancer
[Protocol 14-074]
Voss, Martin, MD